Your browser doesn't support javascript.
loading
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex.
Jochems, Caroline; Tritsch, Sarah R; Knudson, Karin M; Gameiro, Sofia R; Smalley Rumfield, Claire; Pellom, Samuel T; Morillon, Y Maurice; Newman, Robby; Marcus, Warren; Szeto, Christopher; Rabizadeh, Shahrooz; Wong, Hing C; Soon-Shiong, Patrick; Schlom, Jeffrey.
Affiliation
  • Jochems C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Tritsch SR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Knudson KM; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Gameiro SR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Smalley Rumfield C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Pellom ST; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Morillon YM; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Newman R; NantWorks, LLC, Culver City, CA, USA.
  • Marcus W; NantWorks, LLC, Culver City, CA, USA.
  • Szeto C; NantOmics, LLC, Culver City, CA, USA.
  • Rabizadeh S; NantOmics, LLC, Culver City, CA, USA.
  • Wong HC; NantWorks, LLC, Culver City, CA, USA.
  • Soon-Shiong P; NantWorks, LLC, Culver City, CA, USA.
  • Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Oncoimmunology ; 8(2): e1532764, 2019.
Article in En | MEDLINE | ID: mdl-30713787